Al Borg Laboratory
Al Borg Technical Newsletters
HEPATITIS MARKERS
12/06/2003
Features
Hepatitis A
Hepatitis B
Hepatitis C
Hepatitis D
Hepatitis E
Family
Picornavirus
Hepadenavirus
Flavivirus
Satellite
Calcivirus
Genome
RNA
DNA
RNA
RNA
RNA
Incubation period
15 - 40 days
50 - 180 days
1 - 5 months
21- 180 days
2 - 9 weeks
Usual type of onset
Acute
Insidious
Insidious
Acute
Acute
Viremia
transient
prologed
prolonged
prolonged
transient?
Mode of transmission
Oral (fecal)
Usual
No
No
No
Usual
Parenteral
Rare
Usual
Usual
Usual
No
Other
Foodborne or waterborne
Intimate contact,perinatal, sexual
Intimate contact
Intimate contact
Waterborne transmission in developing countries
Carrier
No
Yes
Yes
Yes
No
Chronic hepatitis
Not reported
Yes
Yes
Yes
Not reported
Estimated mortality
0.1% - 0.2%
0.5% - 2.0% (may be higher in complicated cases)
1% - 2% (may be higher in complicated cases)
2% - 20%
20% in pregnant women; 1% - 2% in general population
Hepatocellular carci.
No
Yes
Yes
Yes
No
Tests
HAV antibody IgM
HBs antigen
HCV IgM
Hepatitis D antigen
Hepatitis E IgM
HAV antibody total
HBs antibody
HCV IgG
Hepatitis D IgM
HBe antigen (rDNA)
RIBA or (LIA) + strip
Hepatitis D total
HBe antibody (rDNA)
HCV-RNA Quantitative by branched DNA & PCR
HBc antibody Total (rAg)
HCV Genotype by PCR
HBc antibody IgM (rDNA)
HCV in liver biopsy by ISH
HBV - DNA by PCR
HCV Positive & Negative Strands in Mononuclear Cells.
HBV in liver biopsy by ISH
Print This Newsletter
Back to Technical Newsletters
Home
|
About Us
|
Contact Us
|
Privacy Policy
Copyright © 2003-2004 Al Borg Laboratory. All Right Reserved